Who are our Trainees?
At the end of 2019, we reached a major milestone: UHN COMBIEL had trained over 200 individuals, from high-school through Associate Professor Visiting Scientist level, across 27 institutions and six continents. COMBIEL has trained individuals from the UK (such as Cambridge University), Ireland, France, Switzerland, Italy, USA (including Harvard University), Brazil, China, India, Australia, New Zealand, and Nigeria. Within Canada, trainees have come from nine universities in five provinces. Trainees have come for as short as 5-6 weeks for the intensive summer COMBIEL training program to as long as 5 years for a PhD. Some have either stayed on or returned at different levels of training (Figure 1).
Funding for trainees of the UHN COMBIEL program is diverse: trainees within the COMBIEL initiative are enrolled and funded through various training programs, including CIHR training programs in Molecular Pathology, EIRR21st, STAGE, the OICR Oncology Research and Methods Training Program, various graduate and post-graduate programs, the University of Toronto Comprehensive Research Experience for Medical Students (CREMS) program, pharmaceutical companies, and philanthropic funds.